Nearly a third of employed Americans under 30 used ChatGPT for work: Poll – The Hill

More employed Americans have used the artificial intelligence (AI) tool ChatGPT for work since last year, with the biggest increase among the younger portion of the workforce, according to a Pew Research poll released Tuesday.  

The survey found that 31 percent of employed Americans between 18 and 29 surveyed in February said they have used ChatGPT for tasks at work, up from 12 percent who said the same last March.

The number of employed Americans who said they use ChatGPT for work decreased by age group. Twenty-one percent of employed adults aged 30 to 49 said they use it, up from 8 percent last year, and just 10 percent aged 50 and older said the same, up from only 4 percent last year.

Overall, the share of employed Americans who have used ChatGPT for work rose to double digits in the past year — reaching 20 percent based on the February survey, up from just 8 percent last March. But in general, most Americans still have not used ChatGPT, according to the survey.  

Twenty-three percent of Americans said they have used ChatGPT. That amount is on the rise from July, when 18 percent said the same.  

Use of ChatGPT has particularly spiked among younger adults. Forty-three percent of adults younger than 30 said they have used ChatGPT in the February survey, compared to 27 percent of adults 30 to 49, 17 percent of adults 50 to 64 and 6 percent of adults 65 and older.  

As the tool becomes more popular, OpenAI has also faced scrutiny about risks it presents about the spread of misinformation. OpenAI CEO Sam Altman faced questions about those risks and how it could impact the upcoming election when he testified before the Senate last year.  

Pew found that 38 percent of Americans said they do not trust the information from ChatGPT about the 2024 presidential election. Only 2 percent said they trust it a “great deal” or “quite a bit” and 10 percent said they have “some” trust in ChatGPT.  

The distrust of ChatGPT about information about the 2024 election was fairly evenly split between Republicans and Democrats.  

The survey also found that very few Americans, roughly 2 percent, said they have used the chatbot to find information about the presidential election.  

The survey is based on data from the American Trends Panel created by Pew Research Center and was conducted from Feb. 7-11. A total of 10,133 panelists responded out of 11,117 who were sampled. The margin of error for the full sample of 10,133 respondents is 1.5 percentage points.  

See original here:

Nearly a third of employed Americans under 30 used ChatGPT for work: Poll - The Hill

Opinion: We cant denounce white supremacy only when it surfaces – Chattanooga Times Free Press

Advertisement Advertisement

February 20, 2024 at 6:01 p.m.

by LeBron Hill

When white supremacy shows its ugly head, everyone is quick to denounce it. Rightfully so.

On Saturday, a group of Nazis walked from Nashville's Lower Broadway to the state Capitol while waving flags bearing swastika symbols.

State

See the original post here:

Opinion: We cant denounce white supremacy only when it surfaces - Chattanooga Times Free Press

Donald Trump’s ‘miracle drug’ for COVID killed nearly 17000 people, reveals new study – Hindustan Times

A drug promoted by former US President Donald Trump to cure COVID-19 has been linked to nearly 17,000 deaths, according to a new study. During the COVID pandemic, Trump urged Americans to take hydroxychloroquine (HCQ), an anti-malaria medicine that is also often used to cure rheumatoid arthritis and lupus, claiming that he himself had been taking the miracle drug.

After the outbreak of coronavirus, scientists suggested that HCQ could be effective in treating the deadly virus. On March 28, 2020, the Food and Drug Administration (FDA) approved the drug for an emergency use authorisation and started clinical trials.

While one scientist called the HCQ a "magic bullet" against coronavirus, Trump highlighted the "miracle" recovery made by a COVID infected woman after using the drug.

"The nice part is, it's been around for a long time...if things don't go as planned, it's not going to kill anybody," the ex-US president said during a COVID Taskforce briefing. In a tweet on March 21, 2020, he said that "FDA has moved mountains" and that the drug would be put to use "immediately" as an antidote to curb Covid transmission.

However in June 2020, the FDA revoked the emergency use authorisation of the drug as several studies, including one by New England Journal of Medicine, found HCQ had no benefit on COVID and led to significant surge in the risk of death. The FDA revoked the emergency use authorization on June 15, 2020.

A new study conducted by French researchers has found that nearly 17,000 people across six countries may have died after being prescribed hydroxychloroquine while hospitalized with the illness from March to July 2020 during the first wave of COVID. The research published in the February issue of Biomedicine & Pharmacotherapy shows that increase in the number of deaths was driven by side effects like heart arrhythmia and muscle weakness.

The countries studied were the US, Turkey, Belgium, France, Spain, and Italy.

The US reported the highest numbers of deaths with 12,739, followed by Spain (1,895 deaths), Italy (1,822 deaths), Belgium (240 deaths), France (199 deaths), and Turkey (95 deaths).

The scientists analysed various studies that tracked hospitalisations due to COVID-19 and exposure to the drug and risk related to it.

The researchers said that the number of deaths could be much higher as their study only looked at only six countries between March and July 2020.

See more here:

Donald Trump's 'miracle drug' for COVID killed nearly 17000 people, reveals new study - Hindustan Times